Effect of oxygen on chronic obstructive pulmonary disease

The Worldwide Chronic Obstructive Pulmonary Disease Treatment Industry is Expected to Reach $104 Billion by 2027 - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 7, 2022
Managed Care, Pharmaceutical, Health, Acquisition, Decision-making, USD, Strategic management, Effect of oxygen on chronic obstructive pulmonary disease, Market share analysis, Value, R, Business Growth Fund, COVID-19, Customer support, Growth, Investment, Certification, CAGR, Use, Compound annual growth rate, Retail, Poultry

Which are the products/segments/applications/areas to invest in over the forecast period in the Global Chronic Obstructive Pulmonary Disease Treatment Market?

Key Points: 
  • Which are the products/segments/applications/areas to invest in over the forecast period in the Global Chronic Obstructive Pulmonary Disease Treatment Market?
  • What is the competitive strategic window for opportunities in the Global Chronic Obstructive Pulmonary Disease Treatment Market?
  • What is the market share of the leading vendors in the Global Chronic Obstructive Pulmonary Disease Treatment Market?
  • What modes and strategic moves are considered suitable for entering the Global Chronic Obstructive Pulmonary Disease Treatment Market?

Global Chronic Obstructive Pulmonary Disease Therapeutics Market to 2027 - by Drug Class, Distribution Channel and Region - ResearchAndMarkets.com

Retrieved on: 
Friday, March 25, 2022
Infectious Diseases, Health, Pharmaceutical, Cardiology, Managed Care, CAGR, Market share analysis, USD, Strategic management, Investment, Customer support, Growth, Market share, Certification, Effect of oxygen on chronic obstructive pulmonary disease, Use, Region, COVID-19, Business Growth Fund, Value, R, Acquisition, Decision-making, Pharmaceutical industry, Retail, Medical device

The "Chronic Obstructive Pulmonary Disease Therapeutics Market Research Report by Drug Class, by Distribution Channel, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Chronic Obstructive Pulmonary Disease Therapeutics Market Research Report by Drug Class, by Distribution Channel, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
  • Which are the products/segments/applications/areas to invest in over the forecast period in the Global Chronic Obstructive Pulmonary Disease Therapeutics Market?
  • What is the market share of the leading vendors in the Global Chronic Obstructive Pulmonary Disease Therapeutics Market?
  • What modes and strategic moves are considered suitable for entering the Global Chronic Obstructive Pulmonary Disease Therapeutics Market?

Global Pulse Oximeters Markets, 2021-2027: COVID-19 Impacts, Strategic Developments by Manufacturers & Technological Advancements in Pulse Oximetry - ResearchAndMarkets.com

Retrieved on: 
Monday, February 7, 2022
Medical Devices, Health, FDA, Prevalence, Degenerative disease, Effect of oxygen on chronic obstructive pulmonary disease, CAGR, US, Blood, Growth, Geography, Hospital, Patient, COVID-19, Pet, Medical device

The "Pulse Oximeters Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type; End User and Geography" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Pulse Oximeters Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type; End User and Geography" report has been added to ResearchAndMarkets.com's offering.
  • The growth of the market is attributed to increasing prevalence of respiratory diseases and growing preference for remote patient monitoring.
  • Further, pulse oximeters are useful for patients with cardiac problem, respiratory problems, and chronic obstructive pulmonary diseases.
  • Based on type, the global pulse oximeters market is sub-segmented into fingertip pulse oximeters, handheld pulse oximeters, wrist-worn pulse oximeters, and pediatric pulse oximeters.

National Health Care Associates and Circadia Technologies Announce Partnership to Enhance Positive Health Outcomes for Seniors

Retrieved on: 
Thursday, November 4, 2021
Infection, Rehabilitation, UTI, Technology, Urinary tract infection, Knowledge, COPD, Algorithm, Heart, Partnership, Patient, Breathe Me, Kidney failure, FDA, Public relations, Effect of oxygen on chronic obstructive pulmonary disease, Communication, Risk, Nursing, Time, Disease management, CEO, COVID-19, Awareness, DNP, Health, Hospital, Respiratory rate, Population, GLOBE, Heart failure, Bed, Medicine, Pharmaceutical industry

Three New York State centers in the National Health Care Associates network have used the device since December 2020.

Key Points: 
  • Three New York State centers in the National Health Care Associates network have used the device since December 2020.
  • "Our goal is to offer this technology at all affiliated centers within the National Health Care Associates' network," said Ann Spenard, DNP, RN-BC, Chief Clinical Officer, National Health Care Associates.
  • Please contact Cathy Toscano, Director of Communications and Public Relations, National Health Care Associates, at [email protected] or 516-260-0516 for an invitation.
  • About National Health Care Associates, Inc.
    National Health Care Associates, Inc. (NHCA) is a network of affiliated skilled nursing, rehabilitation and assisted living centers throughout the northeast.